Clinical Trial Update: Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers [Phase 2]

View source ↗

Summary

Phase 2 perioperative regimen of gemcitabine, cisplatin, and pembrolizumab for potentially resectable biliary tract cancers; sponsored by Johns Hopkins and curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemzar (gemcitabine)
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Billiary Track Cancer | Phase 2 | Status: RECRUITING